| First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran—eight years of surveillance M Shamaei, M Marjani, E Chitsaz, M Kazempour, M Esmaeili, P Farnia, ... International Journal of Infectious Diseases 13 (5), e236-e240, 2009 | 113 | 2009 |
| Outcome of treatment of MDR-TB patients with standardised regimens, Iran, 2002–2006 MR Masjedi, P Tabarsi, E Chitsaz, P Baghaei, M Mirsaeidi, MV Amiri, ... The International Journal of Tuberculosis and Lung Disease 12 (7), 750-755, 2008 | 93 | 2008 |
| Incidence, clinical and epidemiological risk factors, and outcome of drug-induced hepatitis due to antituberculous agents in new tuberculosis cases P Baghaei, P Tabarsi, E Chitsaz, M Saleh, M Marjani, S Shemirani, ... American journal of therapeutics 17 (1), 17-22, 2010 | 88 | 2010 |
| Nontuberculous mycobacteria among patients who are suspected for multidrug-resistant tuberculosis—need for earlier identification of nontuberculosis mycobacteria P Tabarsi, P Baghaei, P Farnia, N Mansouri, E Chitsaz, F Sheikholeslam, ... The American journal of the medical sciences 337 (3), 182-184, 2009 | 75 | 2009 |
| Contribution of substance use disorders on HIV treatment outcomes and antiretroviral medication adherence among HIV-infected persons entering jail E Chitsaz, JP Meyer, A Krishnan, SA Springer, R Marcus, N Zaller, ... AIDS and Behavior 17, 118-127, 2013 | 69 | 2013 |
| Post-release substance abuse outcomes among HIV-infected jail detainees: results from a multisite study A Krishnan, JA Wickersham, E Chitsaz, SA Springer, AO Jordan, N Zaller, ... AIDS and Behavior 17, 171-180, 2013 | 53 | 2013 |
| Treatment outcome, mortality and their predictors among HIV-associated tuberculosis patients P Tabarsi, E Chitsaz, A Moradi, P Baghaei, P Farnia, M Marjani, ... International journal of STD & AIDS 23 (9), e1-e4, 2012 | 46 | 2012 |
| Risk factors associated with multidrug-resistant tuberculosis P Baghaei, P Tabarsi, E Chitsaz, A Novin, N Alipanah, M Kazempour, ... TANAFFOS (Respiration) 8 (3 (summer)), 17-21, 2009 | 45 | 2009 |
| Standardised second-line treatment of multidrug-resistant tuberculosis during pregnancy P Tabarsi, A Moradi, P Baghaei, M Marjani, M Shamaei, N Mansouri, ... The International Journal of Tuberculosis and Lung Disease 15 (4), 547-550, 2011 | 44 | 2011 |
| Performance of QuantiFERON-TB Gold test compared to tuberculin skin test in detecting latent tuberculosis infection in HIV-positive individuals in Iran M Mardani, P Tabarsi, Z Mohammadtaheri, E Chitsaz, B Farokhzad, ... Annals of thoracic medicine 5 (1), 43-46, 2010 | 43 | 2010 |
| Impact of extensively drug-resistant tuberculosis on treatment outcome of multidrug-resistant tuberculosis patients with standardized regimen: report from Iran P Tabarsi, E Chitsaz, P Baghaei, M Shamaei, P Farnia, M Marjani, ... Microbial Drug Resistance 16 (1), 81-86, 2010 | 34 | 2010 |
| APECED‐associated hepatitis: clinical, biochemical, histological and treatment data from a large, predominantly American cohort DM Chascsa, EMN Ferré, Y Hadjiyannis, H Alao, M Natarajan, ... Hepatology 73 (3), 1088-1104, 2021 | 32 | 2021 |
| Coexisting venous thromboembolism in patients with tuberculosis1, 2 B Sharif-Kashani, B Bikdeli, A Moradi, P Tabarsi, E Chitsaz, S Shemirani, ... Thrombosis research 125 (5), 478-480, 2010 | 30 | 2010 |
| Biliary atresia: the timing needs a changin’ E Chitsaz, RA Schreiber, JP Collet, J Kaczorowski Canadian Journal of Public Health 100, 475-477, 2009 | 30 | 2009 |
| Drug abuse profile–patient delay, diagnosis delay and drug resistance pattern–among addict patients with tuberculosis M Shamaei, M Marjani, P Baghaei, E Chitsaz, E Rezaei Tabar, ... International journal of STD & AIDS 20 (5), 320-323, 2009 | 29 | 2009 |
| Extensively drug-resistant tuberculosis treatment outcome in Iran: a case series of seven patients MR Masjedi, P Tabarsi, P Baghaei, S Jalali, P Farnia, E Chitsaz, M Amiri, ... International Journal of Infectious Diseases 14 (5), e399-e402, 2010 | 28 | 2010 |
| Utility of gastric lavage for diagnosis of tuberculosis in patients who are unable to expectorate sputum P Baghaei, P Tabarsi, P Farnia, AH Radaei, M Kazempour, YA Faghani, ... Journal of global infectious diseases 3 (4), 339-343, 2011 | 27 | 2011 |
| Revised Category II regimen as an alternative strategy for retreatment of Category I regimen failure and irregular treatment cases P Tabarsi, E Chitsaz, V Tabatabaei, P Baghaei, M Shamaei, P Farnia, ... American journal of therapeutics 18 (5), 343-349, 2011 | 24 | 2011 |
| First-line antituberculosis drug resistance prevalence and its pattern among HIV-infected patients in the national referral tuberculosis centre, Iran P Tabarsi, E Chitsaz, A Moradi, P Baghaei, P Farnia, M Marjani, ... International journal of STD & AIDS 20 (8), 566-570, 2009 | 18 | 2009 |
| Treatment outcome and mortality: Their predictors among HIV/TB co-infected patients from Iran P Tabarsi, E Chitsaz, A Moradi, P Baghaei, M Marjani, D Mansouri The International Journal of Mycobacteriology 1 (2), 82-86, 2012 | 13 | 2012 |
P.TabarsiCTERC, NRITLD, Shahid Beheshti University of Medical Sciences, Tehran, Iran在 sbmu.ac.ir 的电子邮件经过验证
